Name: Pathophysiology of Ischemia Reperfusion Injury and use of Fingolimod in Cardioprotection (en Inglés)
Price: 125320.00 CLP
Availability: InStock
Author: Ahmed Md Phd, Naseer
ISBN: 9780128180235

portada Pathophysiology of Ischemia Reperfusion Injury and use of Fingolimod in Cardioprotection (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Ahmed Md Phd, Naseer

Año

2019

Idioma

Inglés

N° páginas

140

Encuadernación

Tapa Blanda

ISBN13

9780128180235

N° edición

Categorías

Biología

Pathophysiology of Ischemia Reperfusion Injury and use of Fingolimod in Cardioprotection (en Inglés)

Ahmed Md Phd, Naseer (Autor) · Academic Press · Tapa Blanda

Libro Físico

$ 125.320

$ 208.860

Ahorras: $ 83.540

40% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 08 de Julio y el Jueves 18 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Pathophysiology of Ischemia Reperfusion Injury and use of Fingolimod in Cardioprotection (en Inglés)"

Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is a deep examination into the mechanisms of myocardial ischemiareperfusion injury and role of fingolimod as a cardioprotective agent through its antioxidant, anti-apoptotic and anti-inflammatory effects. Dr. Ahmed explore the physiology and pathophysiology of myocardial metabolism under normal and ischemic conditions and focused on pharmacological cardioprotection. They provide a concise, yet rigorous discussion of Ischemia-Reperfusion Injury, Myocardial Ischemia during Circulatory Arrest, Myocardial Reperfusion, Myocardial Protection related to Ischemia-Reperfusion Injury and Role of Fingolimod in Cardioprotection.Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is ideal for researchers, cardiovascular scientists, and clinical pharmacologists to further work in this challenging area and apply this knowledge to clinical trials for cardioprotection.Provides detailed and critical analysis of the latest research in the field from molecular basis to potential clinical relevanceExamines the effect of fingolimod/sphingosine 1-phosphate in cardioprotection, pointing to future myocardial preventative strategies